Die Wachstumsstörung im Zusammenhang mit einem Morbus Crohn wird durch somatische Mutationen im IL6 vermittelt.
1. |
Kühn R et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. |
2. |
Farmer MA et al. (2001) A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. |
3. |
Singh UP et al. (2003) Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice. |
4. |
Asano K et al. (2009) A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. |
5. |
Sawczenko A et al. (2005) Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. |
6. |
Moehle C et al. (2006) Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. |
7. |
Nenci A et al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. |
8. |
Ricciardelli I et al. (2008) Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. |
9. |
Lovato P et al. (2003) Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. |
10. |
Pang YH et al. (2007) Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients. |
11. |
None (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. |
12. |
Hugot JP et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. |
13. |
van Heel DA et al. (2003) The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. |
14. |
Maeda S et al. (2005) Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. |
15. |
van Heel DA et al. () Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. |
16. |
Rivas MA et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. |
17. |
Iliev ID et al. (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. |
18. |
Villani AC et al. (2009) Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. |
19. |
Cao Z et al. (2015) Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation. |
20. |
Lewkonia RM et al. (1976) Progress report. Familial inflammatory bowel disease--heredity or environment? |
21. |
Orholm M et al. (1991) Familial occurrence of inflammatory bowel disease. |
22. |
Monsén U et al. (1989) Evidence for a major additive gene in ulcerative colitis. |
23. |
Küster W et al. (1989) The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. |
24. |
Greenstein AJ et al. (1988) Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. |
25. |
Sheehan RG et al. (1967) Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency. |
26. |
Grönhagen-Riska C et al. (1983) Familial occurrence of sarcoidosis and Crohn's disease. |
27. |
Farmer RG et al. (1980) Studies of family history among patients with inflammatory bowel disease. |
28. |
Schwartz SE et al. (1980) Regional enteritis: evidence for genetic transmission by HLA typing. |
29. |
Targan SR et al. (1995) Clarifying the causes of Crohn's. |
30. |
Hermiston ML et al. (1995) Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. |
31. |
Hugot JP et al. (1994) Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D. |
32. |
Gilberts EC et al. (1994) Molecular evidence for two forms of Crohn disease. |
33. |
Yang H et al. (1993) Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. |
34. |
None (1996) Complex traits on the map. |
35. |
Hugot JP et al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. |
36. |
Satsangi J et al. (1996) Clinical patterns of familial inflammatory bowel disease. |
37. |
Neurath MF et al. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. |
38. |
Mishina D et al. (1996) On the etiology of Crohn disease. |
39. |
Satsangi J et al. (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. |
40. |
Ohmen JD et al. (1996) Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. |
41. |
Parkes M et al. (1996) Susceptibility loci in inflammatory bowel disease. |
42. |
Haapamäki MM et al. (1997) Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. |
43. |
Cho JH et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. |
44. |
Cavanaugh JA et al. (1998) Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. |
45. |
Hampe J et al. (1999) A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. |
46. |
Pizarro TT et al. (1999) IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. |
47. |
Annese V et al. (1999) Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. |
48. |
Cattan D et al. (2000) Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. |
49. |
Rioux JD et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. |
51. |
Lawrance IC et al. (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. |
52. |
Mwantembe O et al. (2001) Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. |
53. |
Cavanaugh J et al. (2001) International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. |
54. |
Dechairo B et al. (2001) Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). |
55. |
None () //// |
56. |
Zouali H et al. (2001) Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. |
57. |
Corbaz A et al. (2002) IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. |
58. |
Miller DH et al. (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. |
59. |
Ghosh S et al. (2003) Natalizumab for active Crohn's disease. |
60. |
von Andrian UH et al. (2003) Alpha4 integrins as therapeutic targets in autoimmune disease. |
61. |
Karban AS et al. (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. |
62. |
Hofseth LJ et al. (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. |
63. |
van Heel DA et al. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. |
64. |
Fuss IJ et al. (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. |
65. |
Lo SH et al. (2004) A demonstration and findings of a statistical approach through reanalysis of inflammatory bowel disease data. |
66. |
Barnich N et al. (2005) GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. |
67. |
McGovern DP et al. (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. |
68. |
Oliver J et al. (2005) A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. |
69. |
Mirza MM et al. (2005) No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. |
70. |
Borm ME et al. (2005) A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. |
71. |
Gonzalez-Rey E et al. (2006) Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. |
72. |
Gaya DR et al. (2006) New genes in inflammatory bowel disease: lessons for complex diseases? |
73. |
Yen D et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. |
74. |
Fellermann K et al. (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. |
75. |
Kullberg MC et al. (2006) IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. |
76. |
Rioux JD et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. |
77. |
Libioulle C et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. |
78. |
Baumgart DC et al. (2007) Inflammatory bowel disease: cause and immunobiology. |
79. |
Barnich N et al. (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. |
80. |
Parkes M et al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. |
81. |
Raelson JV et al. (2007) Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. |
82. |
Cho JH et al. (2007) The genetics of inflammatory bowel disease. |
83. |
None (2008) New links to the pathogenesis of Crohn disease provided by genome-wide association scans. |
84. |
Shugart YY et al. (2008) An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29. |
85. |
Franke A et al. (2008) Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. |
86. |
Zhernakova A et al. (2008) Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. |
87. |
Barrett JC et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. |
88. |
Martínez A et. al. (2008) Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. |
89. |
Franke A et al. (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. |
90. |
None () //// |
91. |
Silverberg MS et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. |
92. |
Weersma RK et al. (2009) Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. |
93. |
Wang K et al. (2009) Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. |
94. |
Glas J et al. (2009) rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. |
95. |
Abraham C et al. (2009) Inflammatory bowel disease. |
96. |
Wang K et al. (2010) Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. |
97. |
Franke A et al. (2010) Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). |
98. |
McGovern DP et al. (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. |
99. |
McGovern DP et al. (2010) Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. |
100. |
Fransen K et al. (2010) Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. |
101. |
Momozawa Y et al. (2011) Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. |
102. |
Khor B et al. (2011) Genetics and pathogenesis of inflammatory bowel disease. |
103. |
Elding H et al. (2011) Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. |
104. |
Jostins L et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. |
105. |
None (1996) Genetics of inflammatory bowel disease. |
106. |
Yoneno K et al. (2013) TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease. |
107. |
Adolph TE et al. (2013) Paneth cells as a site of origin for intestinal inflammation. |
108. |
Monteleone G et al. (2015) Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. |
109. |
Huang H et al. (2017) Fine-mapping inflammatory bowel disease loci to single-variant resolution. |